Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000935836-25-000166·Kalaris Therapeutics, Inc.
Schedule 13G ownership disclosure
ALLOVIR INC COM NEW
Common Stock · CUSIP: 019818202
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- EcoR1 Capital, LLC
Shares: 408,688.00 · Class: 8.1%
- Oleg Nodelman
Shares: 408,688.00 · Class: 8.1%
- EcoR1 Capital Fund Qualified, L.P.
Shares: 385,705.00 · Class: 7.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-25-000166
- Form type
- SCHEDULE 13G/A
- Filer
- Kalaris Therapeutics, Inc.
- CIK
- CIK 1754068
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership